Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-094-1 | CAS number: 25550-51-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
In humans, cyclic anhydrides are mainly absorbed through the respiratory tract by inhalation and are metabolised to the corresponding di-carboxylic acids and excreted in urine.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Little information is available on the toxicokinetics of hexahydromethylphthalic anhydride (MHHPA). Information from the studies conducted on the substance indicates that a degree of absorption does occur by the oral route but the extent of absorption, relative to dose, cannot be judged.
MHHPA is a cyclic anhydride and the cyclic anhydrides have a similar structure, containing a bicyclic ring structure with the carboxylic acid anhydride group being the reactive and toxicologically functional moiety. The bicyclic ring structure may be saturated or partially unsaturated and may contain substituted methyl derivatives. Substances with substituted methyl groups may exist as several isomeric forms. As a result, information from structurally similar substances may be used as a source of information regarding toxicokinetics.
Absorption
No available information on toxicokinetics in experimental animals has been located. In humans, cyclic anhydrides are mainly absorbed through the respiratory tract by inhalation and are metabolised to the corresponding di-carboxylic acids and excreted in urine. In a volunteer study, 5 healthy volunteers have been exposed to hexahydrophthalic anhydride (HHPA) at 80μg/m3for 8 hours (Jönsson BA, Skerfving S (1993) Toxicokinetics and biological monitoring in experimental exposure of humans to gaseous hexahydrophthalic anhydride. Scandinavian Journal of Work, Environment and Health, 19:183–190). During the 8 hour exposure period 1–4% of the substance was found in exhaled air. The urine from a worker exposed to an 8 hour time-weighted average concentration of 30μg/m3has been collected and analysed for 24 hours (Jönsson B, Skarping G (1991) Method for the biological monitoring of hexahydrophthalic anhydride by the determination of hexahydrophthalic acid in urine using gas chromatography and selected-ion monitoring. Journal of Chromatography, 572: 117–131). Greater than 85% of the inhaled dose was excreted in urine as the di-acid, hexahydrophthalic acid.
Jönsson et.al. evaluated the percutaneous absorption of hexahydrophthalic anhydride (HHPA) applied to the skin of 3 human volunteers for 48 hours (Jönsson BA, Welinder H, Hansson C, Ståhlbom B (1993) Occupational exposure to hexahydrophthalic anhydride: Air analysis, percutaneous absorption, and biological monitoring. International Archives of Occupational and Environmental Health, 65: 43–47). Urine was collected over a 72 hour period and analysed. The excreted amounts of hexahydrophthalic acid were 1.4% - 4.5%, 0.2% - 1.3%, and 0% - 0.4% of the applied dose for the three subjects, this indicating minimal absorption of the anhydride.
Distribution
The distribution of hexahydrophthalic anhydride (HHPA) in guinea-pigs and rats exposed by the inhalation route to radio labelled hexahydrophthalic anhydride for a period of 3 – 8 hours has been evaluated (Lindh CH, Jönsson BA, Johannesson G, Zhang XD, Welinder H, Brittebo EB (1999) Binding of the potent allergen hexahydro-phthalic anhydride in the mucosa of the upper respiratory and alimentary tract following single inhalation exposures in guinea pigs and rats. Toxicology, 134: 153–168). Autoradiography revealed lung tissue to contain negligible levels of radioactivity. Medium to high levels were found in the nasal mucosa and trachea. The gastrointestinal tract and conjunctivae of the eyes also showed tissue-bound radioactivity. In the rat, low levels of radioactivity were found in the kidney cortex. Radioactivity in dialysed plasma was found in the same fraction as albumin.
Metabolism and excretion
It has been demonstrated that the anhydride group reacts with amino acids and conjugates readily with proteins. Trimellitic anhydride (TMA) has been shown to conjugate rapidly with human serum albumin in an in-vitro experiment (Zeiss CR, Patterson R, Pruzansky JJ, Miller MM, Rosenberg M, Levitz D (1977) Trimellitic anhydride induced airway syndromes: Clinical and immunologic studies. Journal of Allergy and Clinical Immunology, 60:96–103). Sera from hexahydrophthalic anhydride (HHPA) and methyl hexahydrophthalic anhydride (MHHPA) exposed workers have been shown to contain measurable plasma protein and albumin adduct levels that correlated with exposure (Rosqvist S, Johannesson G, Lindh CH, Jonsson BA (2000) Quantification of protein adducts of hexahydrophthalic anhydride and methylhexahydrophthalic anhydride in human plasma. Journal of Environmental Monitoring, 2:155–160.). The half-life of these adducts was approximately 20 days. In-vitro and in-vivo studies with the lungs of the guinea pig found that methyl tetrahydrophthalic anhydride (MTHPA) was conjugated primarily to lysine in the collagen (Jönsson BA, Wishnok JS, Skipper PL, Stillwell WG, Tannenbaum SR (1995) Lysine adducts between methyl-tetrahydrophthalic anhydride and collagen in guinea pig lung. Toxicology and Applied Pharmacology, 135:156–162). Experiments with human erythrocytes exposed to hexahydrophthalic anhydride (HHPA) or methyl hexahydrophthalic anhydride (MHHPA) showed conjugation with haemoglobin to occur. Hexahydrophthalic anhydride (HHPA) was bound mainly to lysine (Lindh CH, Jönsson BA (1998) Quantification method of human hemoglobin adducts from hexahydrophthalic anhydride and methylhexahydrophthalic anhydride. Journal of Chromatography B, Biomedical Sciences and Applications, 710: 81–90).
Acid anhydrides are excreted in urine as the corresponding dicarboxylic acids.
Blood samples taken from workers exposed to methyl hexahydrophthalic anhydride (MHHPA) at concentrations of 140–310μg/m3had anhydride levels of 3.4–10.7 nmol/l at the end of their work shift (Pfäffli P, Savolainen H (1991) Determination of 4-methyl-cis-hexahydrophthalic anhydride in human blood by gas chromatography with electron-capture detection. Analyst, 116: 1333–1336). The di-acid hydrolysis product was not detected.
It has been reported that analysis of the urine of a worker exposed to a time-weighted average concentration of 30 μg/m3 hexahydrophthalic anhydride (HHPA) showed more than 85% of the inhaled amount to be excreted as hexahydrophthalic acid (Jönsson B and Skarping G (1991) Method for the biological monitoring of hexahydrophthalic anhydride by the determination of hexahydrophthalic acid in urine using gas chromatography and selected-ion monitoring. Journal of Chromatography, 572:117–131).
The half-life of phthalic acid in the urine of workers exposed to phthalic anhydride has been reported to be approximately 14 hours (Pfäffli P (1986) Phthalic acid excretion as an indicator of exposure to phthalic anhydride in the work atmosphere. International Archives of Occupational and Environmental Health, 58: 209–216). Half-lives of the di-acids were estimated to be 7 hours for workers exposed to low levels of methyl hexahydrophthalic anhydride (MHHPA) and 14 hours for workers exposed to hexahydrophthalic anhydride (HHPA) and tetrahydrophthalic anhydride (THPA) (Pfäffli P, Savolainen H, Keskinen H (1989) Determination of carboxylic acids in biological samples as their trichloroethyl esters by gas chromatography. Chromatographia, 27:483–488). An equilibrium between methyl hexahydrophthalic anhydride (MHHPA) and its urinary acid was reached after 4 hours of exposure to a concentration of 116μg/m3. A half-life of 2 – 3 hours for hexahydrophthalic acid in the urine of workers exposed to hexahydrophthalic anhydride (HHPA) has been reported (Jönsson B, Skarping G (1991) Method for the biological monitoring of hexahydrophthalic anhydride by the determination of hexahydrophthalic acid in urine using gas chromatography and selected-ion monitoring. Journal of Chromatography, 572:117–131).
Half-lives of 1.7 – 1.8 hours have been reported for hexahydrophthalic acid in the plasma of 2 male volunteers exposed to hexahydrophthalic anhydride (HHPA) at a concentration of 80μg/m3for 8 hours (Jönsson BA, Skerfving S (1993) Toxicokinetics and biological monitoring in experimental exposure of humans to gaseous hexahydrophthalic anhydride. Scandinavian Journal of Work, Environment and Health, 19:183–190).
Results of analysis of the urine from a worker exposed to methyl tetrahydrophthalic anhydride (MTHPA) has indicated half-lives of 3, 3, and 6 hours for the 3 isomers, 3-methyl-delta 4-tetrahydrophthalic anhydride, 4-methyl-delta 4-tetrahydrophthalic anhydride, and 4-methyl-delta 3-tetrahydrophthalic anhydride, respectively (Lindh CH, Jönsson BA (1994) Method for analysis of methyl-tetrahydrophthalic acid in urine using gas chromatography and selected ion monitoring. Journal of Chromatography B, Biomedical Applications, 660: 57–66).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)